Inventor · disambiguated record
Dale Miles
Also filed as: MILES DALE · MILES DALE A
7 granted patents·5 pending applications·241 citations·filing 1995–2023
88Inventor score
Top patents by PatentIndex Score
12 records- 0190US11141413B2Method of treating renal cell carcinoma using N-(4-(6,7-dimethoxyquinolin-4-yloxy)phenyl)-N′-(4-fluorophenyl)cyclopropane-1,1-dicarboxamide, (2S)-hydroxybutanedioateEXELIXIS INC·Filed 2017·Granted Oct 12, 2021·8 cites·21 claims
- 0287US5631943APortable X-ray deviceFiled 1995·Granted May 20, 1997·100 cites·17 claims
- 0384US7160873B2Texaphyrin coordination compounds and uses thereofPHARMACYCLICS INC·Filed 2005·Granted Jan 9, 2007·11 cites·8 claims
- 0483US6736776B2Method for diagnosing and interpreting dental conditionsINTERACTIVE DIAGNOSTIC IMAGING·Filed 2002·Granted May 18, 2004·38 cites·25 claims
- 0577US2024350477A1Method of Treating Renal Cell Carcinoma Using N-(4-(6,7-dimethoxyquinolin-4-yloxy)phenyl)-N’-(4-fluorophenyl)cyclopropane-1,1-dicarboxamide, (2S)-hydroxybutanedioateEXELIXIS INC·Filed 2023·Application pending·0 cites
- 0673US2022401433A1Method of Treating Renal Cell Carcinoma Using N-(4-(6,7-dimethoxyquinolin-4-yloxy)phenyl)-N'-(4-fluorophenyl)cyclopropane-1,1-dicarboxamide, (2S)-hydroxybutanedioateEXELIXIS INC·Filed 2022·Application pending·0 cites
- 0769US2023045783A9Method of Treating Renal Cell Carcinoma Using N-(4-(6,7-dimethoxyquinolin-4-yloxy)phenyl)-N'-(4-fluorophenyl)cyclopropane-1,1-dicarboxamide, (2S)-hydroxybutanedioateEXELIXIS INC·Filed 2021·Application pending·0 cites
- 0863US6919327B2Texaphyrin coordination compounds and uses thereofPHARMACYCLICS INC·Filed 2001·Granted Jul 19, 2005·2 cites·25 claims
- 0957US5781610APortable X-ray deviceFiled 1997·Granted Jul 14, 1998·20 cites·2 claims
- 1052US2006128638A1Texaphyrin coordination compounds and uses thereofPHARMACYCLICS INC·Filed 2006·Application pending·0 cites
- 1149US6038287APortable X-ray deviceFiled 1998·Granted Mar 14, 2000·62 cites·40 claims
- 1238US2005053199A1Portable x-ray device and methodFiled 2003·Application pending·0 cites
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →